Could a brain chemical blocker prevent Stress-Linked depression?
NCT ID NCT06786637
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to see if a drug called LY-2940094 could protect healthy adults from developing depression- or anxiety-like symptoms after stress. Researchers planned to give the drug to participants and then measure their brain responses to rewards and fear. However, the trial was withdrawn before any volunteers were enrolled, so no data was collected.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Nociceptin Receptor Antagonist (LY-2940094)
What this could lead to
If successful, this research could point toward a new way to prevent stress-triggered depression or anxiety by targeting the brain's N/OFQ system.
What could go wrong
The study was withdrawn before enrolling anyone, so no results exist. It was also a small, early-phase mechanistic study in healthy volunteers, not patients, so any real-world treatment would be far off.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.